Correlation of Stromal Cells by Morphometric Analysis with Metastatic Behavior of Human Colonic Carcinoma

Cancer Research

Volumn 49, Issue 21, 1989, Pages 5989-5993

  McGinnis, Michael C ^a   Bradley, Edwin L ^c   Pretlow, Theresa P ^a   Ortiz Reyes, Ruben ^a   Bowden, Christopher J ^a   Stellato, Thomas A ^b   Pretlow, Thomas G ^a  

^a Departments of Pathology   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLON CARCINOMA; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HUMAN CELL; METASTASIS; MORPHOMETRICS; PRIORITY JOURNAL; STROMA CELL;

COLON; COLONIC NEOPLASMS; EOSINOPHILS; HUMAN; INFLAMMATION; INTESTINAL MUCOSA; NEOPLASM METASTASIS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024461567     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Pretlow, T. P., Keith, E. F., Cryar, A. K., Bartloucci, A. A., Pitts, A. M., Pretlow, T. G., Kimball, P. M., and Boohaker, E. A. Eosinophil infiltration of human colonie carcinomas as a prognostic indicator. Cancer Res., 43: 2997–3000, 1983.
2. Ioachim, H. L. Correlations between tumor antigenicity, malignant potential, and local host immune response. Contemp. Top. Immunobiol., 10: 213–238, 1980.
3. Pretlow, T. P., Boohaker, E. A., Pitts, A. M., Macfadyen, A. J., Bradley, E. L., Jr., and Pretlow, T. G. Heterogeneity and subcompartmentalization in the distribution of eosinophils in human colonic carcinomas. Am. J. Pathol., 7/6:207–213, 1984.
4. Yoon, I. L. The eosinophil and gastrointestinal carcinoma. Am. J. Surg., 97: 195–200, 1959.
5. Kolb, E., and Muller, E. Local responses in primary and secondary human lung cancers. II. Clinical correlations. Br. J. Cancer, 40:410–416, 1979.
6. Iwasaki, K., Torisu, M., and Fujimura, T. Malignant tumor and eosinophils I. Prognostic significance in gastric cancer. Cancer (Phila.), 58: 1321–1327, 1986.
7. Bostrom, S. C., and Hart, W. R. Carcinomas of the cervix with intense stromal eosinophilia. Cancer (Phila.), 47:2887–2893, 1981.
8. Luebbers, E. L., Pretlow, T. P., Emancipator, S. N., Boohaker, E. A., Pitts, A. M., Macfadyen, A. J., Bradley, E. L., Jr., and Pretlow, T. G. Heterogeneity and prognostic significance of macrophages in human colonic carcinomas. Cancer Res., 45: 5196–5200, 1985.
9. Weisz-Carrington, P., Poger, M. E., and Lamm, M. E. Secretory immunoglobulins in colonic neoplasms. Am. J. Pathol., 85: 303–316, 1976.
10. Green, F. H. Y., Whitehead, S., and Fox, H. Abnormalities of the local immune system in intestinal neoplasia: a morphological study. J. Pathol., 722:55–62, 1977.
11. Rognum, T. O., Brandtzaeg, P., Baklien, K., and Hognestad, J. Immuno-globulin-producing cells in the “transitional” mucosa adjacent to adenocarcinomas of the human large bowel. Int. J. Cancer, 23: 165–173, 1979.
12. Allen, C., and Hogg, N. Elevation of infiltrating mononuclear phagocytes in human colorectal tumors. J. Natl. Cancer Inst., 78:465–470, 1987.
13. Watt, A. G., and House, A. K. Colonic carcinoma: a quantitative assessment of lymphocyte infiltration at the periphery of colonic tumors related to prognosis. Cancer (Phila.), 41:279–282, 1978.
14. Russell, S. W., Witz, I. P., and Herberman, R. B. A review of data, problems, and open questions pertaining to in situ tumor immunity. Contemp. Top. Immunobiol., 10:1–20, 1980.
15. Soufleris, A. J., Pretlow, T. P., Bartolucci, A. A., Pitts, A. M., Macfadyen, A. J., Boohaker, E. A., and Pretlow, T. G. Cytologic characterization of pulmonary alveolar macrophages by enzyme histochemistry in plastic. J. Histochem. Cytochem., 57: 1412–1418, 1983.
16. Beckstead, J. H., and Bainton, D. F. Enzyme histochemistry on bone marrow biopsies: reactions useful in the differential diagnosis of leukemia and lymphoma applied to 2-micron plastic sections. Blood, 55: 386–394, 1980.
17. Beckstead, J. H., Halverson, P. S., Ries, C. A., and Bainton, D. F. Enzyme histochemistry and immunohistochemistry on biopsy specimens of pathologic human bone marrow. Blood, 57:1088–1098, 1981.
18. Pretlow, T. P., Grane, R. W., Goehring, P. L., Lapinsky, A. S., and Pretlow, T. G. Examination of enzyme-altered foci with 7-glutamyl transpeptidase, aldehyde dehydrogenase, glucose-6-phosphate dehydrogenase, and other markers in methacrylate-embedded liver. Lab. Invest., 56: 96–100, 1987.
19. Pretlow, T. P., Lapinsky, A. S., Flowers, L. C., Grane, R. W., and Pretlow, T. G. Enzymatic histochemistry of mouse kidney in plastic. J. Histochem. Cytochem., 35:483–487, 1987.
20. Barka, T., and Anderson, P. J. Histochemistry: Theory, Practice, and Bibliography, pp. 85–86. New York: Harper and Row, Publishers, Inc., 1965.
21. Zar, J. H. Biostatistical Analysis, pp. 109–114, 124–126, 243–245. Engle-wood Cliffs, NJ: Prentice Hall, 1974.
22. Cottier, H., Turk, J., and Sobin, L. A proposal for a standardized system of reporting human lymph node morphology in relation to immunological function. Bull. W. H. O., 47: 375–408, 1972.
23. MacCarty, W. C. Factors which influence longevity in cancer. Ann. Surg., 76:9–12,1922.
24. Spratt, J. S., Jr., and Spjut, H. J. Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma. Cancer (Phila.), 20: 1976–1985, 1967.
25. Hopker, W.W., Wurster, K. H., Donnert, G., Haag, D., and Hehl, F.-J. Correlation and cluster analytic studies about histological characteristics of the colon-rectum-carcinoma. Virchows Arch. A Pathol. Anat. Histol., 363: 273–285, 1974.
26. Underwood, J. C. E. Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review. Br. J. Cancer, 30: 538–548, 1974.
27. Murray, D., Hreno, A., Dutton, J., and Hampson, L. G. Prognosis in colon cancer. A pathologic reassessment. Arch. Surg., 110:903–913, 1975.
28. Zamcheck, N., Doos, W. G., Prudente, R., Lurie, B. B., and Gottlieb, L. S. Prognostic factors in colon carcinoma: correlation of serum carcinoem-bryonic antigen level and tumor histopathology. Hum. Pathol., 6: 31–45, 1975.
29. Pihl, E., Malahy, M. A., Khankhanian, N., Hersh, E. M., and Mavligit, G. M. Immunomorphological features of prognostic significance in Dukes' Class B colorectal carcinoma. Cancer Res., 37:4145–4149, 1977.
30. Syrjanen, K. J., and Hjelt, L. H. Tumor-host relationships in colorectal carcinoma. Dis. Colon Rectum, 27:29–36, 1978.
31. Werkmeister, J. A., Pihl, E., Nind, A. P. P., Flannery, G. R., and Nairn, R. C. Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma. Br. J. Cancer, 40: 839–847, 1979.
32. Werkmeister, J. A., Pihl, E., Hughes, E. S. R., Cuthbertson, A. M., and Rollo, A. J. Lymphoreticular cells within primary colorectal carcinoma: a surface marker study. Clin. Immunol. Immunopathol., 18:415–424, 1981.
33. Nacopoulou, L., Azaris, P., Papacharalampous, N., and Davaris, P. Prognostic significance of histologic host response in cancer of the large bowel. Cancer (Phila.), 47:930–936,1981.
34. Svennevig, J-L., Lunde, O. C., and Holter, J. In situ analysis of the inflammatory cell infiltrates in colon carcinomas and in the normal colon wall. Acta Pathol. Microbiol. Immunol. Scand. Sect. A, 90:131–137, 1982.
35. Svennevig, J-L., Lunde, O. C., Holter, J., and Bjorgsvik, D. Lymphoid infiltration and prognosis in colorectal carcinoma. Br. J. Cancer, 49: 375–377, 1984.
36. Koch, B., Giedl, J., Hermanek, P., and Kalden, J. R. The analysis of mononuclear cell infiltrations in colorectal adenocarcinoma. J. Cancer Res. Clin. Oncol., 109: 142–151, 1985.
37. Berg, J. W. Inflammation and prognosis in breast cancer. A search for host resistance. Cancer (Phila.), 72: 714–720, 1959.
38. Ioachim, H. L., Dorsett, B. H., and Paluch, E. The immune response at the tumor site in lung carcinoma. Cancer (Phila.), 38:2296–2309, 1976.
39. Cronin, W. J., Dorsett, B. H., and Ioachim, H. L. Isolation of lung carcinoma-associated antibodies from immune complexes and production of heterologous antisera. Cancer Res., 42: 292–300, 1982.
40. Ioachim, H. L. The stromal reaction of tumors: an expression of immune surveillance. J. Natl. Cancer Inst., 57:465–475, 1976.
41. Vaage, J., and Pepin, K. G. Plasma cell infiltrate of the primary tumor as a source of early systemic protection against metastases in mice. J. Natl. Cancer Inst., 71: 147–155, 1983.
42. Rosenberg, S. A. Immunotherapy of patients with advanced cancer using interleukin-2 alone or in combination with lymphokine activated killer cells. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Important Advances in Oncology 1988, pp. 217–257. Philadelphia: J. B. Lippincott Company, 1988.
43. Wolmark, N., Fisher, B., Rockette, H., Redmond, C., Wickerham, D. L., Fisher, E. R., Jones, J., Glass, A., Lerner, H., Lawrence, WM Prager, D., Wexler, M., Evans, J., Cruz, A., Dimitrov, N., Jochimsen, P., and other NSABP investigators. Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. J. Natl. Cancer Inst., 80: 30–36, 1988.